This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (9)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Lee M. Jampol, MD

Arch Ophthalmol. 1991;109(6):789-790.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

The Macular Photocoagulation Study (MPS), a multicenter randomized clinical trial that is evaluating photocoagulation for treatment of choroidal neovascularization from age-related macular degeneration (AMD), presumed ocular histoplasmosis, and idiopathic choroidal neovascular membranes, has provided important guidelines for therapy.^1-4 One aspect of the study that has received relatively little attention is the interplay between systemic hypertension and choroidal neovascularization. In 1979, when the MPS began enrolling patients, there was no reason to suspect that systemic hypertension would play an important role in the clinical outcomes. Although it was plausible that an increase in intraluminal pressures in choroidal vessels might contribute to visual loss in treated or untreated eyes, there was little or no evidence to support this hypothesis. The study included measurement of blood pressure in all patients. Analysis of the outcomes in patients with and without hypertension has produced some interesting results.

The MPS defined a patient as having . . . [Full Text PDF of this Article]

Author Affiliations
Chicago, Ill

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?